Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objectives of this study are to assess the feasibility and efficacy of a combination
chemotherapy (PVAG) in elderly patients with advanced stages Hodgkin's lymphoma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Cologne
Collaborators:
Eli Lilly and Company German Hodgkin's Lymphoma Study Group